Zepatier Approved for Chronic Hepatitis C
Liver disease affects some 3 million Americans
Continue Reading
Liver disease affects some 3 million Americans
Continue Reading
Problem affects almost two-thirds of those taking tenofovir in sub-Sahara AfricaContinue Reading
FDA says it’s first liposarcoma drug to improve survival
Continue Reading
FDA says it’s first liposarcoma drug to improve survival
Continue Reading
New analysis finds much greater risk of aggression, self-harmContinue Reading
Patients taking Tysabri were more prone to show signs of exposure to JCV, which can cause a brain diseaseContinue Reading
Belatacept showed long-term benefits over older immune-suppressing drug, but costs moreContinue Reading
They run risk of stomach bleeds, ulcers, liver damage from meds, doctors sayContinue Reading
Finds treatment works and is well-tolerated in 2- to 5-year-oldsContinue Reading
But study doesn’t prove cause-and-effectContinue Reading
© 2021 WeeklyMD.com - All Rights Reserved.